PD64-06 MTDH PROMOTES METASTASIS OF CLEAR CELL RENAL CELL CARCINOMA BY ACTIVATING SND1-MEDIATED ERK SIGNALING AND EPITHELIAL-MESENCHYMAL TRANSITION

Anbang He,Liqun Zhou
DOI: https://doi.org/10.1097/ju.0000000000000981.06
2020-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology III (PD64)1 Apr 2020PD64-06 MTDH PROMOTES METASTASIS OF CLEAR CELL RENAL CELL CARCINOMA BY ACTIVATING SND1-MEDIATED ERK SIGNALING AND EPITHELIAL-MESENCHYMAL TRANSITION Anbang He* and Liqun Zhou Anbang He*Anbang He* More articles by this author and Liqun ZhouLiqun Zhou More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000981.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Metastasis accounts for the principal reason for renal cell carcinoma-associated mortality. Metadherin (MTDH) was identified to be as a vital metastasis driver involved in the metastatic progression of various types of tumors, suggesting that MTDH could be a prognostic metastatic biomarker and potential therapeutic target. By now, the role and mechanism of MTDH in the metastatic progression of ccRCC still have not been adequately explored yet. METHODS: The MTDH/SND1 mRNA expression of clear cell renal cell carcinoma (ccRCC) was comprehensively estimated in GEO-ccRCC and TCGA-KIRC datsets by R software and packages. The MTDH protein expression was assessed in a total of 111 ccRCC patients from Peking University First Hospital by Immunohistochemistry (IHC). In vitro migration, invasion assays and in vivo metastatic mouse model were conducted to investigate the biological functions of MTDH in ccRCC cells. Correlation analysis, immunoprecipitation, western blot and immunofluorescence were applied to explore the molecular mechanisms of MTDH in ccRCC. RESULTS: Compared with normal kidney tissues, MTDH was remarkably elevated in ccRCC, especially in metastatic ccRCC and correlated with advanced clinicopathological features and poor prognosis. MTDH activated ERK signaling and EMT, thus promoting cell migration and invasion of ccRCC. The interaction between MTDH and SND1 at the protein level was confirmed using immunoprecipitation and immunofluorescence. Based on the analysis of GEO and TCGA data, SND1 was remarkably increased in ccRCC, especially in metastatic ccRCC and associated with advanced clinicopathological features and poor prognosis. Knockdown of SND1 mainly abolished cell migration and invasion of ccRCC by blocking MTDH mediated ERK and EMT signaling activation. CONCLUSIONS: The results revealed MTDH could be a prognostic metastatic biomarker of ccRCC and promoted ccRCC metastasis by activating SND1-mediated EMT and ERK and EMT signaling pathways. MTDH may server as a potential anti-tumor therapeutic target that could be applied for the clinical treatment of metastatic ccRCC. Source of Funding: This work was supported by the National Natural Science Foundation of China [81672546, 81602253, 81772703, 81872083, 81972379], Natural Science Foundation of Beijing [7152146, 7172219] and The Capital Health Research and Development of Special [2016–1-4077]. © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1300-e1302 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Anbang He* More articles by this author Liqun Zhou More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?